Background. It is known that a predominant glomerular deposition of IgG4 is characteristic of idiopathic membranous nephropathy (MN) and that significant deposition of other IgG subclasses is also observed in lupus MN. However, there is no report focusing on the distribution of glomerular IgG subclass deposits in MN patients with anti-U1 ribonucleoprotein (RNP) antibody. Methods. We evaluated clinicopathological features and the distribution patterns of glomerular IgG subclass deposits in seven MN patients with positive anti-RNP antibody and negative antibodies to double-stranded DNA (dsDNA) and Smith antigen (Sm) (RNP-MN group) and in seven age-and sex-matched lupus MN patients with positive anti-dsDNA antibody and negative antibodies to RNP and Sm (L-MN group). Results. Mixed connective tissue disease was diagnosed in four patients in the RNP-MN group. Two patients in the RNP-MN group and three patients in the L-MN group developed nephrotic syndrome. Renal insufficiency was not present in all patients in both groups. Hypocomplementemia was found in two patients in the RNP-MN group and six patients in the L-MN group. In the RNP-MN group, positive stainings for glomerular IgG1, IgG2, IgG3 and IgG4 were observed in one, seven, zero and five patients, respectively. On the contrary, in the L-MN group, positive stainings for glomerular IgG1, IgG2, IgG3 and IgG4 were observed in seven, seven, seven, and six patients, respectively. Conclusions. This is the first study showing striking differences in the distribution of glomerular IgG subclass deposits between RNP-MN and L-MN groups. RNP-MN and L-MN may result from different immunological mechanisms.
Introduction
Membranous nephropathy (MN), the common cause of the adult nephrotic syndrome, is characterized by glomerular sub-epithelial deposits of IgG and complement [1] . Human IgG is divided into four subclasses, IgG1, IgG2, IgG3 and IgG4, according to antigenic differences in their heavy chains. Each subclass differs in complement-activating ability [2] . Several studies, including our previous studies, have shown different distribution patterns of glomerular IgG subclass deposition between idiopathic MN (I-MN) and secondary MN (S-MN) associated with systemic lupus erythematosus (SLE) [3] [4] [5] [6] [7] , drug or toxin [8, 9] and malignancy [10] . These findings suggest that I-MN and S-MN may result from different immunological mechanisms.
Mixed connective tissue disease (MCTD) is defined by a combination of clinical and serological features: features similar to those of SLE, systemic sclerosis and polymyositis, associated with anti-U1 ribonucleoprotein (RNP) antibody [11] . However, there is still controversy as to the concept of MCTD such as whether it is an independent disease entity or a preliminary stage of other identified collagen diseases: whether MCTD can be credited with the term 'disease' awaits the demonstration of common etiopathological events underlying the development of antibodies to RNP and their associated clinical features [12] . A variety of renal diseases have been described in 10-50% of MCTD patients [13] : almost 10% of renal-biopsied MCTD patients is MN. Although the pathogenesis of MN secondary to MCTD may be SLE related, the exact immunological mechanisms remain unclear. To our knowledge, there is no report focusing on the glomerular distribution of IgG subclasses in patients with MN-associated anti-RNP antibody.
In the present study, we examined distribution patterns of glomerular IgG subclass deposits in seven MN patients with positive anti-RNP antibody and negative antibodies to double-stranded DNA (dsDNA) and Smith antigen (Sm) (RNP-MN group including four MCTD patients) and in seven lupus MN patients with positive anti-dsDNA antibody and negative antibodies to RNP and Sm (L-MN group). We found different distribution patterns between the two groups.
Materials and methods

Patients
This study was based on the renal histological records (1979-2010) of 5104 patients (excluding pediatric patients and transplant patients) studied at Akita University Hospital and its affiliated hospitals. Renal biopsies were performed in all patients after obtaining informed consent. There were seven MN patients with positive anti-RNP antibody and negative antibodies to dsDNA and Sm. Clinicopathological features and the distribution patterns of glomerular IgG subclass deposits in these patients were evaluated. The diagnosis of MCTD was made according to the diagnostic criteria proposed by the Research Committee of Japanese Ministry of Health and Welfare [11] . As a control group, seven age-and sex-matched L-MN patients with positive anti-dsDNA antibody and negative antibodies to RNP and Sm, who fulfilled the American College of Rheumatology criteria for SLE [14] , were randomly selected. Clinical and laboratory information on each patient was obtained at the time of renal biopsy. Nephrotic syndrome was defined as urinary protein !3.5 g/day, hypoalbuminemia (serum albumin 3.0 g/dL) and edema. Renal insufficiency was defined as a serum creatinine !1.2 mg/dL. Hypocomplementemia was defined as serum C3 <70 mg/dL or C4 <20 mg/dL.
Pathological studies
The renal biopsy specimens were processed using standard techniques for light, immunofluorescence and electron microscopy. Determination of IgG subclasses was performed on cryostat sections or formalin-fixed paraffin-embedded sections. For immunofluorescence microscopy, cryostat sections were stained with mouse monoclonal antibodies to human IgG1 (clone 8c/6-39), IgG2 (clone HP6014), IgG3 (clone HP6050) and IgG4 (clone HP6025) (The Binding Site, Birmingham, UK), followed by fluorescein isothiocyanate-conjugated anti-mouse IgG (Cappel, Aurora, OH), as described previously [15] . When cryostat sections were not available, immunohistochemistry was performed on formalin-fixed paraffin-embedded sections. After blocking endogenous peroxidase activity, the sections were incubated with mouse monoclonal antibodies described above, followed by anti-mouse IgG conjugated to peroxidase-labeled dextran polymer and then they were visualized with a DAB-substrate chromogen system (DAKO, Glostrup, Denmark). The sections that were incubated with mouse IgG1 and the secondary antibody served as negative controls.
Statistical assessment
We compared clinicopathological parameters between the RNP-MN group and L-MN group, using the Mann-Whitney U-test or v 2 test. All analyses were performed using an Excel Statistical Software (Igakutosho Shuppan, Tokyo, Japan). A P-value <0.05 was regarded as statistically significant.
Results
Clinical features
Clinical features in seven patients in the RNP-MN group are shown in Table 1 . Six patients were females. The median age was 37 years (range 27-72). All patients had Raynaud's phenomenon. Four patients (Cases 1, 2, 5 and 7) fulfilled diagnostic criteria for MCTD [11] : Case 1 with polyarthralgia and an elevated serum level of creatine phosphokinase; Case 2 with leukopenia and pulmonary fibrosis; Case 5 with polyarthritis, leukopenia and sclerodactyly and Case 7 with swollen fingers, polyarthritis, sclerodactyly, and an elevated serum level of creatine phosphokinase.
Laboratory data in patients in the RNP-MN and L-MN groups are shown in Table 2 . In the RNP-MN group, all patients had proteinuria or hematuria: two patients (Cases 2 and 5) developed nephrotic syndrome. Renal insufficiency was not present in all patients. Hypocomplementemia was found in two patients. Anti-dsDNA antibody or anti-Sm antibody was not detected in all patients. In the L-MN group, all patients had proteinuria including tubular proteinuria with or without hematuria: three patients (Cases 9, 11 and 12) developed nephrotic syndrome. Renal insufficiency was not present in all patients. Hypocomplementemia was found in six patients (Cases 8-11, 13 and 14). Anti-RNP antibody or anti-Sm antibody was not detected in all patients. Anti-SS-A antibody was detected in four patients in the RNP-MN group and in six patients in the L-MN group. Anti-SS-B-antibody was detected in one patient in L-MN group.
Statistical analysis (Table 2) showed that serum C4 level was significantly lower in the L-MN group than in the RNP-MN group, but there were no significant differences in other parameters, such as amount of urinary protein and serum levels of creatinine, albumin and C3 between the two groups. There was no significant difference in the frequency of antibodies to SS-A and SS-B between the two groups.
Renal histological findings
Glomerular histological findings in the RNP-MN and L-MN groups, including immunofluorescence or immunohistochemical findings, for each patient are shown in Table 3 . Tubulointerstitial and vascular alterations were mild or absent in all patients. IgG granular deposits along the glomerular capillary walls were observed in all patients. No, or trace, stainings for IgA, IgM, C3, and C1q were observed in two of the seven patients in the RNP-MN group (Cases 6 and 7), whereas these stainings were almost positive in all seven patients in L-MN group. Glomerular-positivity patterns of IgG subclasses in each patient are shown in Table 4 . In seven patients in the RNP-MN group, positive stainings for IgG1, IgG2, IgG3 and IgG4 were observed in one, seven, zero and five patients, respectively. In the seven patients in the L-MN group, positive stainings for IgG1, IgG2, IgG3 and IgG4 were observed in seven, seven, seven and six patients, respectively. Statistical analysis showed that the glomerular staining intensities of IgG1 and IgG3 were significantly stronger in L-MN group than in RNP-MN group.
Discussion
MCTD was first described in 1972 by Sharp et al. [16] as a disease syndrome with a combination of features of SLE, systemic sclerosis and polymyositis, associated with a specific antibody to an extractable nuclear antigen (subsequently designated RNP). In their series of 25 patients, Raynaud's phenomenon and swollen fingers were frequently observed. Renal disease was considered to be rarely accompanied by MCTD: only one patient developed renal disease. In subsequent studies, the incidence of renal involvement has varied from 10 to 26% of adult patients with MCTD [13] . The pathology of MCTD is pleomorphic with glomerular lesions resembling the spectrum found in SLE and vascular lesions resembling those found in systemic sclerosis. Glomerular disease is most common, and a variety of renal diseases including MN have been described in a MCTD series in Western countries [13] . Takasaki et al. [17] examined the pattern of renal involvement in MCTD patients followed at a single Japanese center. Of 61 patients, 35 patients (57.4%) had intermittent proteinuria (!0.5 g/day) and 15 patients (24.6%) had persistent proteinuria (!0.5 g/day). Renal biopsy was performed in 17 patients. The most frequent diagnosis was normal or minimal change (41.2%), followed by focal segmental or diffuse proliferative glomerulonephritis (35.2%), diffuse MN (11.8%) and mesangial alterations (11.8%).
Although the pathogenesis of MN secondary to MCTD may be SLE related, the exact immunological mechanisms remain unclear. To our knowledge, this is the first report to show striking differences in distribution patterns of glomerular IgG subclass deposits between RNP-MN and L-MN groups. Several studies compared distribution patterns of glomerular IgG subclass deposits between I-MN (or non-lupus-MN) and L-MN [3] [4] [5] [6] [7] . Doi et al. [3] observed a predominance of IgG4 in I-MN and a predominance of IgG1 and IgG3 in L-MN. Haas [4] found relative intensity of IgG3 >IgG4 in L-MN but not in non-lupus-MN. Our previous study showed that staining intensities of IgG1, IgG2 and IgG3 were stronger in L-MN than in I-MN and that staining intensity of IgG4 was stronger in I-MN than in L-MN [5] . Kuroki et al. [6] reported that IgG1, IgG2, IgG3 and, to a lesser degree, IgG4 were similarly present in L-MN, whereas IgG4 was the predominant subclass in I-MN. Zuniga et al. [7] reported a predominance of IgG2 and IgG3 in L-MN. In the present study, similar findings were observed in seven patients in the L-MN group. On the contrary, in seven patients in the RNP-MN group (including four MCTD patients), there was a marked predominance of IgG2: positive glomerular staining for IgG3 was not observed in all patients and positive glomerular staining for IgG1 was observed in only one patient. These findings suggest that the pathogenesis of glomerular IgG deposition may be different between RNP-MN and L-MN groups. Zouali et al. [18] examined IgG subclass distribution of autoantibodies to dsDNA and RNP in 44 SLE patients and 13 MCTD patients. They found that anti-dsDNA antibodies were relatively restricted to IgG1 and IgG3, whereas anti-RNP antibodies were essentially restricted to IgG2, in accordance with our renal biopsy findings. IgG1 and IgG3 are effective activators of the classical complement pathway, whereas IgG2 and IgG4 are weak or non-activators of the classical complement pathway [2] . In our patients, hypocomplementemia was found in two of seven patients in RNP-MN group and six of seven patients in L-MN group. On renal biopsy sections, intermediate or strong stainings for C3 and/or C1q were observed in two of seven patients in the RNP-MN group and six of seven patients in the L-MN group. These results can be explained by the variation in complement-activating ability among IgG subclasses predominantly deposited in the glomeruli.
Reichlin and Van Venrooij [19] observed high titers of anti-RNP antibody and the almost universal presence of antibody to U1-70K protein in the RNP complex in patients with MCTD. On the contrary, lower averaged titers of anti-RNP antibody and the absence of antibody to U1-70K protein were found predominantly in nonoverlap SLE patients. The frequency of antibody to U1-70K protein was inversely related to the frequency of nephritis in their patients, although the meaning of this relationship was uncertain [19] . Kattah et al. [20] recently reviewed structural properties of the RNP complex relating to the autoimmune pathogenesis in rheumatic diseases. They proposed that the RNP complex plays a central role in the autoimmune pathogenesis in most patients with MCTD and in a subset of SLE patients. The U1-RNA components and U1-specific proteins, particularly specific epitopes within the U1-70K protein, engage immune cells and their receptors in a complex network of interactions that ultimately lead to inflammation and tissue injury. It is possible that there are differences in the autoimmune response against some specific components of the RNP complex between glomerulonephritis in MCTD and lupus nephritis.
In conclusion, the present study focusing on the glomerular IgG subclass distribution suggests that RNP-MN and L-MN may result from different immunological mechanisms.
